Immunovant Stock Investor Trims Stake, Still Bullish
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Biotech Investing
On this Biotech Investing tag page, 5 recent articles cover innovative biotech stocks, Agios moves, Arcellx updates, Cogent Biosciences and more, giving you quick, actionable finance insights.
76 articlesWhy BioNTech Stock Getting Crushed Today: A Deep Dive Analysis
BioNTech’s stock is under pressure as investors react to weak guidance and leadership pivots. This deep dive breaks d...
Under‑the‑Radar Biotech Potential Growth: 10X Bets
Investing in small biotech stocks offers the potential for outsized gains — but only with a clear process. This guide...
Investment Manager Loads CELC Stock: Fresh Insight for 2025
A noteworthy fund increased its Celcuity stake by 135,000 shares, signaling potential catalysts and shifting risk. Le...
Don't Even Think About Regencell Stock Until You See Flag
Regencell Bioscience sits in the high-risk, high-reward world of early-stage biotech. Before you consider investing, ...
Liquidia (LQDA) 2025 Earnings: Key Takeaways for Investors
As Liquidia releases its Q4 2025 results, investors crave clarity on revenue, burn rate, and milestones. This article...
Verastem (VSTM) 2025 Earnings Outlook for Investors
As Verastem prepares for its 2025 earnings outlook, investors should focus on cash runway, collaboration milestones, ...
Investment Advisor Bets CMPX Stock: Big Stake Signals Conviction
A prominent investment advisor added a sizable CMPX position, signaling strong conviction in Compass Therapeutics. He...
Compugen (CGEN) 2025 Earnings Outlook for Investors
A forward-looking look at Compugen's 2025 earnings. Learn how pipeline progress, partnerships, and cash runway could ...
Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Disc Medicine Lands Million: Investors React to FDA Catalyst
A private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...
Disc Medicine Stock Swinging, Yet a Fund Bet Shines
A leading hedge fund just disclosed a sizable new stake in Disc Medicine. This article breaks down what Disc Medicine...
Related Topics
#Earnings Analysis (17)
#Stock Analysis (14)
#Portfolio Management (14)
#Stock Market (10)
#Investing (8)
#Portfolio Strategy (7)
#risk-management (6)
#Hedge Funds (5)
#Investment Strategy (4)
#Earnings (4)
#SEC Filings (4)
#Healthcare Stocks (3)
#portfolio-allocation (3)
#Stock Market News (3)
#Insider Trading (3)